Percutaneous transhepatic balloon dilatation of benign biliary strictures.

Percutaneous transhepatic balloon dilatation of benign biliary strictures. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Percutaneous transhepatic balloon dilatation of benign biliary strictures. Abstract Text:

J J Trambert,K M Bron,A B Zajko,T E Starzl,S Iwatsuki,

Between February 1981 and June 1984, 15 patients with benign biliary strictures were treated with percutaneous transhepatic balloon dilatation. Three of these patients had received liver transplants. The treatment began with a course of balloon dilatation therapy, after which a stent catheter was left across the stricture. Six weeks later, after duct patency had been shown by cholangiography, the stent catheter was removed from all but two patients, both of whom had intrahepatic sclerosing cholangitis. After this procedure, six patients (40%), including two liver-transplant patients, were stricture-free after one treatment for periods ranging from 27 to 56 months, and were considered to be treatment successes. Nine patients (60%) suffered stricture recurrences. In eight of these patients, the stricture was heralded by symptoms of either cholangitis or jaundice; in one patient, who was on permanent catheter drainage, the stricture was discovered only on follow-up cholangiography. All successfully treated patients had only one stricture, while all patients with more than one stricture suffered recurrences. Our data also suggest a greater responsiveness for anastomotic strictures than for non-anastomotic strictures. Of the patients with recurrences, five had symptom-free intervals of 23 months or more (up to 31 months). The fact that strictures recurred after such long periods of time underscores the importance of long-term follow-up. In view of the number of patients helped, the favorable experience with post-liver-transplantation strictures, and the lack of any major complications in our series, percutaneous biliary balloon dilatation offers a viable alternative to surgical management of benign biliary strictures.

Percutaneous transhepatic balloon dilatation of benign biliary strictures. Publishing Authors By Initials

JJ Trambert,KM Bron,AB Zajko,TE Starzl,S Iwatsuki,

For similar pathological conditions, signs and symptoms: pathologic processes: sclerosis research abstracts see: pathological conditions, signs and symptoms: pathologic processes: sclerosis research

PUBMED ID PMID:

MEDLINE DATE:

Percutaneous transhepatic balloon dilatation of benign biliary strictures. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: AJR. American journal of roentgenology

VOLUME: 149

Page Numbers: 945-8

Journal Abbreviation:

ISSN: 0361-803X

DAY: 15

MONTH: Nov

YEAR: 1987

Percutaneous transhepatic balloon dilatation of benign biliary strictures. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7708173

Percutaneous transhepatic balloon dilatation of benign biliary strictures. Keywords Mesh Terms:

KEYWORDS: Sclerosis

MESH TERMS: surgery

Chemical & Substance for Abstract: Percutaneous transhepatic balloon dilatation of benign biliary strictures. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Percutaneous transhepatic balloon dilatation of benign biliary strictures.

AFFILIATION: Department of Radiology, Presbyterian University Hospital, Pittsburgh, PA 15213.

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: AJR Am J Roentgenol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Percutaneous transhepatic balloon dilatation of benign biliary strictures Related Publications

• A novel homozygous mutation of the EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformis.
• Effects of orally administered bovine lactoperoxidase on dextran sulfate sodium-induced colitis in mice.
• Fibroblast attachment to Arg-Gly-Asp peptide-immobilized poly(gamma-methyl L-glutamate).
• Gangrenous staphylococcal infections localized on the lesions of acquired reactive perforating collagenosis.
• In vitro Th1 cytokine-independent Th2 suppressive effects of bifidobacteria.
• Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient.
• Karyotypic analysis of bone marrow cells in pyodermic lesions associated with myelodysplastic syndrome.
• Leukocyte common antigen-negative, aggressive cutaneous anaplastic large cell lymphoma with prominent pseudocarcinomatous hyperplasia.
• Percutaneous transhepatic balloon dilatation of benign biliary strictures.
• Purification and properties of deoxythymidine kinase induced by bacteriophage T4 infection.
• Recombinant human intelectin binds bovine lactoferrin and its peptides.
• Recovery from Sézary syndrome following Mycobacterium avium spondylitis.
• Tracing of the molecular remnants of herpes virus infections in necrotic skin tissue.
• Unilateral ashy dermatosis occurring in a child.